Does Sera Prognostics pay a dividend?

Sera Prognostics does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Sera Prognostics financially healthy?

Sera Prognostics carries a debt-to-equity ratio of 0.04x and a current ratio of 2.12x, with a market beta of 0.97. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Sera Prognostics a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sera Prognostics (SERA) the key facts are: market cap $83M, revenue $81,000, 52-week range 1.56-3.95. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Sera Prognostics's full fundamentals live

Get Sera Prognostics's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.